Evolution, Expression and Meiotic Behavior of Genes Involved in Chromosome Segregation of Monotremes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Meiotic Cohesin and Variants Associated with Human Reproductive Aging and Disease
fcell-09-710033 July 27, 2021 Time: 16:27 # 1 REVIEW published: 02 August 2021 doi: 10.3389/fcell.2021.710033 Meiotic Cohesin and Variants Associated With Human Reproductive Aging and Disease Rachel Beverley1, Meredith L. Snook1 and Miguel Angel Brieño-Enríquez2* 1 Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States, 2 Magee-Womens Research Institute, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA, United States Successful human reproduction relies on the well-orchestrated development of competent gametes through the process of meiosis. The loading of cohesin, a multi- protein complex, is a key event in the initiation of mammalian meiosis. Establishment of sister chromatid cohesion via cohesin rings is essential for ensuring homologous recombination-mediated DNA repair and future proper chromosome segregation. Cohesin proteins loaded during female fetal life are not replenished over time, and therefore are a potential etiology of age-related aneuploidy in oocytes resulting in Edited by: decreased fecundity and increased infertility and miscarriage rates with advancing Karen Schindler, Rutgers, The State University maternal age. Herein, we provide a brief overview of meiotic cohesin and summarize of New Jersey, United States the human genetic studies which have identified genetic variants of cohesin proteins and Reviewed by: the associated reproductive phenotypes -
Atrec8 and Atscc3 Are Essential to the Monopolar Orientation of the Kinetochores During Meiosis
Research Article 4621 AtREC8 and AtSCC3 are essential to the monopolar orientation of the kinetochores during meiosis Liudmila Chelysheva, Stéphanie Diallo*, Daniel Vezon, Ghislaine Gendrot, Nathalie Vrielynck, Katia Belcram, Nathalie Rocques, Angustias Márquez-Lema‡, Anuj M. Bhatt§, Christine Horlow, Raphaël Mercier, Christine Mézard and Mathilde Grelon¶ Institut Jean-Pierre Bourgin, Station de Génétique et d’Amélioration des Plantes, INRA de Versailles, Route de Saint-Cyr, 78026 Versailles CEDEX, France *Present address: Laboratoire de Microbiologie du Froid UPRES 2123, 55 Rue Saint-Germain, 27000 Evreux, France ‡Present address: Instituto de Agricultura Sostenible (CSIC), Apartado 4084, E-14080, Córdoba, Spain §Present address: Department of Plant Sciences, University of Oxford, South Parks Road, Oxford, OX1 3RB, UK ¶Author for correspondence (e-mail: [email protected]) Accepted 13 July 2005 Journal of Cell Science 118, 4621-4632 Published by The Company of Biologists 2005 doi:10.1242/jcs.02583 Summary The success of the first meiotic division relies (among other in meiotic nuclei as early as interphase, and bound to the factors) on the formation of bivalents between homologous chromosome axis from early leptotene through to anaphase chromosomes, the monopolar orientation of the sister I. We show here that both AtREC8 and AtSCC3 are kinetochores at metaphase I and the maintenance of necessary not only to maintain centromere cohesion at centromeric cohesion until the onset of anaphase II. The anaphase I, but also for the monopolar orientation of the meiotic cohesin subunit, Rec8 has been reported to be one kinetochores during the first meiotic division. We also of the key players in these processes, but its precise role in found that AtREC8 is involved in chromosome axis kinetochore orientation is still under debate. -
Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis
Research Article Phosphorylation and Activation of Cell Division Cycle Associated 8 by Aurora Kinase B Plays a Significant Role in Human Lung Carcinogenesis Satoshi Hayama,1,2 Yataro Daigo,1 Takumi Yamabuki,1 Daizaburo Hirata,1 Tatsuya Kato,1 Masaki Miyamoto,2 Tomoo Ito,3 Eiju Tsuchiya,4 Satoshi Kondo,2 andYusuke Nakamura 1 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan; Departments of 2Surgical Oncology and 3Surgical Pathology, Hokkaido University Graduate School of Medicine, Sapporo, Japan; and 4Kanagawa Cancer Center Research Institute, Kanagawa, Japan Abstract inhibitors for EGFR tyrosine kinase (i.e., gefitinib and erlotinib), Through genome-wide gene expression analysis of lung were developed and are applied in clinical practice (5). However, carcinomas, we detected in the great majority of lung cancer each of the new regimens can provide survival benefits to a small samples cotransactivation of cell division cycle associated subset of the patients (6, 7). Hence, new therapeutic strategies, such 8(CDCA8) and aurora kinase B (AURKB), which were as development of more effective molecular targeted agents considered to be components of the vertebrate chromosomal applicable to the great majority of patients with less toxicity, are passenger complex.Immunohistochemical analysis of lung eagerly awaited. cancer tissue microarrays showed that overexpression of Systematic analysis of expression levels of thousands of genes CDCA8 and AURKB was significantly associated with poor using cDNA microarrays is an effective approach for identification prognosis of lung cancer patients.AURKB directly phosphor- of unknown molecules involved in carcinogenic pathways and can ylated CDCA8 at Ser154, Ser219, Ser275, and Thr278 and seemed effectively screen candidate target molecules for development of to stabilize CDCA8 protein in cancer cells.Suppression of novel therapeutics and diagnostics. -
Redundant and Specific Roles of Cohesin STAG Subunits in Chromatin Looping and Transcriptional Control
Downloaded from genome.cshlp.org on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Research Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control Valentina Casa,1,6 Macarena Moronta Gines,1,6 Eduardo Gade Gusmao,2,3,6 Johan A. Slotman,4 Anne Zirkel,2 Natasa Josipovic,2,3 Edwin Oole,5 Wilfred F.J. van IJcken,1,5 Adriaan B. Houtsmuller,4 Argyris Papantonis,2,3 and Kerstin S. Wendt1 1Department of Cell Biology, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 2Center for Molecular Medicine Cologne, University of Cologne, 50931 Cologne, Germany; 3Institute of Pathology, University Medical Center, Georg-August University of Göttingen, 37075 Göttingen, Germany; 4Optical Imaging Centre, Erasmus MC, 3015 GD Rotterdam, The Netherlands; 5Center for Biomics, Erasmus MC, 3015 GD Rotterdam, The Netherlands Cohesin is a ring-shaped multiprotein complex that is crucial for 3D genome organization and transcriptional regulation during differentiation and development. It also confers sister chromatid cohesion and facilitates DNA damage repair. Besides its core subunits SMC3, SMC1A, and RAD21, cohesin in somatic cells contains one of two orthologous STAG sub- units, STAG1 or STAG2. How these variable subunits affect the function of the cohesin complex is still unclear. STAG1- and STAG2-cohesin were initially proposed to organize cohesion at telomeres and centromeres, respectively. Here, we uncover redundant and specific roles of STAG1 and STAG2 in gene regulation and chromatin looping using HCT116 cells with an auxin-inducible degron (AID) tag fused to either STAG1 or STAG2. Following rapid depletion of either subunit, we perform high-resolution Hi-C, gene expression, and sequential ChIP studies to show that STAG1 and STAG2 do not co-occupy in- dividual binding sites and have distinct ways by which they affect looping and gene expression. -
Centromere RNA Is a Key Component for the Assembly of Nucleoproteins at the Nucleolus and Centromere
Downloaded from genome.cshlp.org on September 23, 2021 - Published by Cold Spring Harbor Laboratory Press Letter Centromere RNA is a key component for the assembly of nucleoproteins at the nucleolus and centromere Lee H. Wong,1,3 Kate H. Brettingham-Moore,1 Lyn Chan,1 Julie M. Quach,1 Melisssa A. Anderson,1 Emma L. Northrop,1 Ross Hannan,2 Richard Saffery,1 Margaret L. Shaw,1 Evan Williams,1 and K.H. Andy Choo1 1Chromosome and Chromatin Research Laboratory, Murdoch Childrens Research Institute & Department of Paediatrics, University of Melbourne, Royal Children’s Hospital, Parkville 3052, Victoria, Australia; 2Peter MacCallum Research Institute, St. Andrew’s Place, East Melbourne, Victoria 3002, Australia The centromere is a complex structure, the components and assembly pathway of which remain inadequately defined. Here, we demonstrate that centromeric ␣-satellite RNA and proteins CENPC1 and INCENP accumulate in the human interphase nucleolus in an RNA polymerase I–dependent manner. The nucleolar targeting of CENPC1 and INCENP requires ␣-satellite RNA, as evident from the delocalization of both proteins from the nucleolus in RNase-treated cells, and the nucleolar relocalization of these proteins following ␣-satellite RNA replenishment in these cells. Using protein truncation and in vitro mutagenesis, we have identified the nucleolar localization sequences on CENPC1 and INCENP. We present evidence that CENPC1 is an RNA-associating protein that binds ␣-satellite RNA by an in vitro binding assay. Using chromatin immunoprecipitation, RNase treatment, and “RNA replenishment” experiments, we show that ␣-satellite RNA is a key component in the assembly of CENPC1, INCENP, and survivin (an INCENP-interacting protein) at the metaphase centromere. -
Supplementary Information Material and Methods
MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Supplementary Information Material and methods Chemicals The EGFR inhibitor NVP-AEE788 (Novartis), the Jak inhibitor I (Merck Calbiochem, #420099) and anisomycin (Alomone labs, # A-520) were prepared as 50 mM stock solutions in 100% DMSO. Doxorubicin (Adriablastin, Pfizer), EGF (Sigma Ref: E9644), PDGF (Sigma, Ref: P4306) and IL-4 (Sigma, Ref: I-4269) stock solutions were prepared as recommended by the manufacturer. For in vivo administration: Temodal (20 mg Temozolomide capsules, Essex Chemie AG, Luzern) was dissolved in 4 mL KZI/glucose (20/80, vol/vol); Taxotere was bought as 40 mg/mL solution (Sanofi Aventis, France), and prepared in KZI/glucose. Antibodies The primary antibodies used were as follows: anti-S473P-Akt (#9271), anti-T308P-Akt (#9276,), anti-S9P-GSK3β (#9336), anti-T389P-p70S6K (#9205), anti-YP/TP-Erk1/2 (#9101), anti-YP/TP-p38 (#9215), anti-YP/TP-JNK1/2 (#9101), anti-Y751P-PDGFR (#3161), anti- p21Cip1/Waf1 (#2946), anti-p27Kip1 (#2552) and anti-Ser15-p53 (#9284) antibodies were from Cell Signaling Technologies; anti-Akt (#05-591), anti-T32P-FKHRL1 (#06-952) and anti- PDGFR (#06-495) antibodies were from Upstate; anti-IGF-1R (#SC-713) and anti-EGFR (#SC-03) antibodies were from Santa Cruz; anti-GSK3α/β (#44610), anti-Y641P-Stat6 (#611566), anti-S1981P-ATM (#200-301), anti-T2609 DNA-PKcs (#GTX24194) and anti- 1 MCT-11-0474 BKM120: a potent and specific pan-PI3K inhibitor Y1316P-IGF-1R were from Bio-Source International, Becton-Dickinson, Rockland, GenTex and internal production, respectively. The 4G10 antibody was from Millipore (#05-321MG). -
Download Paper
M BoC | ARTICLE Chromosomal passenger complex hydrodynamics suggests chaperoning of the inactive state by nucleoplasmin/nucleophosmin Mariah L. Hanleya,b, Tae Yeon Yooc, Matthew Sonnetta, Daniel J. Needlemanc,d, and Timothy J. Mitchisona,* aDepartment of Systems Biology, Harvard Medical School, Boston, MA 02114–5701; bDepartment of Chemistry, cJohn A. Paulson School of Engineering and Applied Sciences, and dDepartment of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138-2902 ABSTRACT The chromosomal passenger complex (CPC) is a conserved, essential regulator of Monitoring Editor cell division. As such, significant anti–cancer drug development efforts have been focused on Yixian Zheng targeting it, most notably by inhibiting its AURKB kinase subunit. The CPC is activated by Carnegie Institution AURKB-catalyzed autophosphorylation on multiple subunits, but how this regulates CPC in- Received: Dec 20, 2016 teractions with other mitotic proteins remains unclear. We investigated the hydrodynamic Revised: Mar 27, 2017 behavior of the CPC in Xenopus laevis egg cytosol using sucrose gradient sedimentation and Accepted: Apr 4, 2017 in HeLa cells using fluorescence correlation spectroscopy. We found that autophosphoryla- tion of the CPC decreases its sedimentation coefficient in egg cytosol and increases its diffu- sion coefficient in live cells, indicating a decrease in mass. Using immunoprecipitation coupled with mass spectrometry and immunoblots, we discovered that inactive, unphosphorylated CPC interacts with nucleophosmin/nucleoplasmin proteins, which are known to oligomerize into pentamers and decamers. Autophosphorylation of the CPC causes it to dissociate from nucleophosmin/nucleoplasmin. We propose that nucleophosmin/nucleoplasmin complexes serve as chaperones that negatively regulate the CPC and/or stabilize its inactive form, pre- venting CPC autophosphorylation and recruitment to chromatin and microtubules in mitosis. -
Detection Rate. FC: Fold Change. GO: Gene Ontology. AUC: Area Under
Figure S1. Flow chart of the study. DR: detection rate. FC: fold change. GO: Gene Ontology. AUC: area under curve. KEGG: Kyoto Encyclopedia of Genes and Genomes. GEO: Gene Expression Omnibus. Figure S2. Independent validation of miRNAs and the classifier. A, ΔCt of 6 selected miRNAs in the independent cohort. *, P < 0.05. **, P < 0.01. ***, P < 0.001. B, Receiver operating curve of the classifier in the independent cohort. AUC: area under curve. Figure S3. Venn of predicted target genes from 3 platforms. Figure S4. GO enrichment analysis. GO: Gene Ontology. Table S1. miRNA expression profile in screening stage. Table S2. miRNA expression profile in validation stage. Table S3. Efficacy of the classifier. Table S4. miRNA expression profile in independent validation stage. Table S5. Predicted target genes. Table S6a. KEGG enrichment analysis. KEGG: Kyoto Encyclopedia of Genes and Genomes. Table S6b. GO_BP enrichment analysis. GO: Gene Ontology. BP: Biological Process. Table S6c. GO_CC enrichment analysis. CC: Cellular Component. Table S6d. GO_MF enrichment analysis. MF: Molecular Function. Table S7. GEO expression array datasets involved in this study. GEO: Gene Expression Omnibus. Table S8a. Predicted target genes covered by the selected GEO datasets. GEO: Gene Expression Omnibus. 1 Table S8b. Expression profiles of predicted target genes of hsa-miR-26b-5p in GEO datasets. Table S8c. Expression profiles of predicted target genes of hsa-miR-146b-5p in GEO datasets. Table S8d. Expression profiles of predicted target genes of hsa-miR-191-5p in GEO datasets. Table S8e. Expression profiles of predicted target genes of hsa-miR-484 in GEO datasets. -
Kinase Profiling Book
Custom and Pre-Selected Kinase Prof iling to f it your Budget and Needs! As of July 1, 2021 19.8653 mm 128 196 12 Tyrosine Serine/Threonine Lipid Kinases Kinases Kinases Carna Biosciences, Inc. 2007 Carna Biosciences, Inc. Profiling Assays available from Carna Biosciences, Inc. As of July 1, 2021 Page Kinase Name Assay Platform Page Kinase Name Assay Platform 4 ABL(ABL1) MSA 21 EGFR[T790M/C797S/L858R] MSA 4 ABL(ABL1)[E255K] MSA 21 EGFR[T790M/L858R] MSA 4 ABL(ABL1)[T315I] MSA 21 EPHA1 MSA 4 ACK(TNK2) MSA 21 EPHA2 MSA 4 AKT1 MSA 21 EPHA3 MSA 5 AKT2 MSA 22 EPHA4 MSA 5 AKT3 MSA 22 EPHA5 MSA 5 ALK MSA 22 EPHA6 MSA 5 ALK[C1156Y] MSA 22 EPHA7 MSA 5 ALK[F1174L] MSA 22 EPHA8 MSA 6 ALK[G1202R] MSA 23 EPHB1 MSA 6 ALK[G1269A] MSA 23 EPHB2 MSA 6 ALK[L1196M] MSA 23 EPHB3 MSA 6 ALK[R1275Q] MSA 23 EPHB4 MSA 6 ALK[T1151_L1152insT] MSA 23 Erk1(MAPK3) MSA 7 EML4-ALK MSA 24 Erk2(MAPK1) MSA 7 NPM1-ALK MSA 24 Erk5(MAPK7) MSA 7 AMPKα1/β1/γ1(PRKAA1/B1/G1) MSA 24 FAK(PTK2) MSA 7 AMPKα2/β1/γ1(PRKAA2/B1/G1) MSA 24 FER MSA 7 ARG(ABL2) MSA 24 FES MSA 8 AurA(AURKA) MSA 25 FGFR1 MSA 8 AurA(AURKA)/TPX2 MSA 25 FGFR1[V561M] MSA 8 AurB(AURKB)/INCENP MSA 25 FGFR2 MSA 8 AurC(AURKC) MSA 25 FGFR2[V564I] MSA 8 AXL MSA 25 FGFR3 MSA 9 BLK MSA 26 FGFR3[K650E] MSA 9 BMX MSA 26 FGFR3[K650M] MSA 9 BRK(PTK6) MSA 26 FGFR3[V555L] MSA 9 BRSK1 MSA 26 FGFR3[V555M] MSA 9 BRSK2 MSA 26 FGFR4 MSA 10 BTK MSA 27 FGFR4[N535K] MSA 10 BTK[C481S] MSA 27 FGFR4[V550E] MSA 10 BUB1/BUB3 MSA 27 FGFR4[V550L] MSA 10 CaMK1α(CAMK1) MSA 27 FGR MSA 10 CaMK1δ(CAMK1D) MSA 27 FLT1 MSA 11 CaMK2α(CAMK2A) MSA 28 -
Comprehensive Identification of Survival-Associated Genes for Cancers
bioRxiv preprint doi: https://doi.org/10.1101/526285; this version posted January 22, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Comprehensive identification of survival-associated genes for cancers Hongde Liu1*, Kun Luo2, Huamei Li1, Xiao Sun1 1State Key Laboratory of Bioelectronics, School of Biological Science & Medical Engineering, Southeast University, Nanjing 210096, China 2Department of Neurosurgery, Xinjiang Evidence-Based Medicine Research Institute, First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China *The corresponding author: Hongde Liu, e-mail: [email protected] (HDL). Authors’ e-mails: Hongde Liu: [email protected] (HDL); Kun Luo: [email protected] (KL); Huamei Li: [email protected](HML); Xiao Sun: [email protected](XS). Highlights: ● The number of possible prognostic and diagnostic genes for cancers; ● A list of independent prognostic genes for each cancer; ● The universal prognostic genes mainly function in the spindle assembly checkpoint; ● Statistical links between mutated pathways and prognostic genes. 1 bioRxiv preprint doi: https://doi.org/10.1101/526285; this version posted January 22, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Abstract: Prognostic signature is important in estimating cancer risk, subtyping cancer, and planning treatment. -
Loss of Cohesin Complex Components STAG2 Or STAG3 Confers Resistance to BRAF Inhibition in Melanoma
Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Shen, C., S. H. Kim, S. Trousil, D. T. Frederick, A. Piris, P. Yuan, L. Cai, et al. 2016. “Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma.” Nature medicine 22 (9): 1056-1061. doi:10.1038/nm.4155. http:// dx.doi.org/10.1038/nm.4155. Published Version doi:10.1038/nm.4155 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:31731818 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Nat Med Manuscript Author . Author manuscript; Manuscript Author available in PMC 2017 March 01. Published in final edited form as: Nat Med. 2016 September ; 22(9): 1056–1061. doi:10.1038/nm.4155. Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma Che-Hung Shen1, Sun Hye Kim1, Sebastian Trousil1, Dennie T. Frederick2, Adriano Piris3, Ping Yuan1, Li Cai1, Lei Gu4, Man Li1, Jung Hyun Lee1, Devarati Mitra1, David E. Fisher1,2, Ryan J. Sullivan2, Keith T. Flaherty2, and Bin Zheng1,* 1Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 2Department of Medical Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 3Department of Dermatology, Brigham & Women's Hospital and Harvard Medical School, Boston, MA 4Division of Newborn Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA. -
Phosphorylation of Threonine 3 on Histone H3 by Haspin Kinase Is Required for Meiosis I in Mouse Oocytes
ß 2014. Published by The Company of Biologists Ltd | Journal of Cell Science (2014) 127, 5066–5078 doi:10.1242/jcs.158840 RESEARCH ARTICLE Phosphorylation of threonine 3 on histone H3 by haspin kinase is required for meiosis I in mouse oocytes Alexandra L. Nguyen, Amanda S. Gentilello, Ahmed Z. Balboula*, Vibha Shrivastava, Jacob Ohring and Karen Schindler` ABSTRACT a lesser extent. However, it is not known whether haspin is required for meiosis in oocytes. To date, the only known haspin substrates Meiosis I (MI), the division that generates haploids, is prone to are threonine 3 of histone H3 (H3T3), serine 137 of macroH2A and errors that lead to aneuploidy in females. Haspin is a kinase that threonine 57 of CENP-T (Maiolica et al., 2014). Knockdown or phosphorylates histone H3 on threonine 3, thereby recruiting Aurora inhibition of haspin in mitotically dividing tissue culture cell kinase B (AURKB) and the chromosomal passenger complex lines reveal that phosphorylation of H3T3 is essential for the (CPC) to kinetochores to regulate mitosis. Haspin and AURKC, an alignment of chromosomes at the metaphase plate (Dai and AURKB homolog, are enriched in germ cells, yet their significance Higgins, 2005; Dai et al., 2005), regulation of chromosome in regulating MI is not fully understood. Using inhibitors and cohesion (Dai et al., 2009) and establishing a bipolar spindle (Dai overexpression approaches, we show a role for haspin during MI et al., 2009). In mitotic metaphase, phosphorylation of H3T3 is in mouse oocytes. Haspin-perturbed oocytes display abnormalities restricted to kinetochores, and this mark signals recruitment of the in chromosome morphology and alignment, improper kinetochore– chromosomal passenger complex (CPC) (Dai et al., 2005; Wang microtubule attachments at metaphase I and aneuploidy at et al., 2010; Yamagishi et al., 2010).